A guide to interpreting economic studies in infectious diseases

Slides:



Advertisements
Similar presentations
Microbial culturomics: paradigm shift in the human gut microbiome study J.-C. Lagier, F. Armougom, M. Million, P. Hugon, I. Pagnier, C. Robert, F. Bittar,
Advertisements

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
L. Boyanova  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Herpes zoster in non-hospitalized children
European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection.
Risk factors for cryptococcal infection among patients with rheumatoid arthritis receiving different immunosuppressive medications  T.-L. Liao, Y.-M.
Migrant health—a cause for concern?
Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia—a propensity-adjusted analysis  G. Choudhury,
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Candida glabrata fungaemia in intensive care units
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008–2013  L.E.B. Nabarro, R.A. Lever, M. Armstrong,
Nosocomial bloodstream infections in children: an 8-year experience at a tertiary-care hospital in Finland  E. Sarvikivi, O. Lyytikäinen, M. Vaara, H.
Clinical Microbiology and Infection
Surveillance of Legionnaires’ disease in Austria
Impact of infection on admission and of the process of care on mortality of patients admitted to the Intensive Care Unit: the INFAUCI study  J. Gonçalves-Pereira,
Vector control: a cornerstone in the malaria elimination campaign
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
P. Seng, J.M. Rolain, D. Raoult, P. Brouqui 
B. Gordts  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
B. Y. Lee, Z. S. Wettstein, S. M. McGlone, R. R. Bailey, C. A
M. Or, M. Samish, T. Waner, S. Harrus 
Elements of design: the knowledge on which we build
Coupled microbial and human systems: evidence for a relationship between infectious disease and gross national product  T.G. Bromage  Clinical Microbiology.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Acute schistosomiasis, a diagnostic and therapeutic challenge
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
A. Bryskier  Clinical Microbiology and Infection 
The practice of travel medicine in Europe
Systematic review of antibiotic consumption in acute care hospitals
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Identification of risk factors associated with nosocomial infection by rotavirus P4G2, in a neonatal unit of a tertiary-care hospital  R. Herruzo, F.
Effect of metronidazole versus standard care on length of stay of patients admitted with severe infectious mononucleosis: a randomized controlled trial 
Current experience in treating invasive zygomycosis with posaconazole
H. Leblebicioglu, C. Eroglu  Clinical Microbiology and Infection 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre  R.R. Laffer, P. Graber, P.E. Ochsner, W. Zimmerli 
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
A. Manzur, F. Gudiol  Clinical Microbiology and Infection 
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
Three years experience of real-time PCR for the diagnosis of Q fever
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

A guide to interpreting economic studies in infectious diseases R.R. Roberts, E.K. Mensah, R.A. Weinstein  Clinical Microbiology and Infection  Volume 16, Issue 12, Pages 1713-1720 (December 2010) DOI: 10.1111/j.1469-0691.2010.03366.x Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Multiple-distribution allocation of support cost to service departments to calculate full cost of patient care. Fte, full-time equivalent employee; SF, square-footage. Clinical Microbiology and Infection 2010 16, 1713-1720DOI: (10.1111/j.1469-0691.2010.03366.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Efficiency—allocative, technical, and economic. QALY, quality-adjusted life-year. Clinical Microbiology and Infection 2010 16, 1713-1720DOI: (10.1111/j.1469-0691.2010.03366.x) Copyright © 2010 European Society of Clinical Infectious Diseases Terms and Conditions